发明公开
EP2598500A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
审中-公开
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HEMMUNG DES JAK-SIGNALWEGES
- 专利标题： COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
- 专利标题（中）： ZUSAMMENSETZUNGEN UND VERFAHREN ZUR HEMMUNG DES JAK-SIGNALWEGES
-
申请号： EP11745858.8申请日： 2011-07-27
-
公开(公告)号： EP2598500A1公开(公告)日： 2013-06-05
- 发明人: LI, Hui , HECKRODT, Thilo, J. , CHEN, Yan , MCMURTRIE, Darren, John , TAYLOR, Vanessa , SINGH, Rajinder , DING, Pingyu , YEN, Rose
- 申请人： Rigel Pharmaceuticals, Inc.
- 申请人地址： 1180 Veterans Boulevard South San Francisco, CA 94080 US
- 专利权人： Rigel Pharmaceuticals, Inc.
- 当前专利权人： Rigel Pharmaceuticals, Inc.
- 当前专利权人地址： 1180 Veterans Boulevard South San Francisco, CA 94080 US
- 代理机构： Sexton, Jane Helen
- 优先权： US368570P 20100728
- 国际公布： WO2012015972 20120202
- 主分类号： C07D413/12
- IPC分类号： C07D413/12 ; C07D413/14 ; A61K31/506 ; A61P27/00 ; A61P37/06
摘要：
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds.
公开/授权文献
- EP2598500B1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY 公开/授权日：2021-05-19
信息查询
